Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer.

Autor: Wadhwa, Vivek K.1, Weston, Robin1, Parr, Nigel J.1
Zdroj: BJU International. Apr2010, Vol. 105 Issue 8, p1082-1088. 7p. 3 Charts, 3 Graphs.
Databáze: Academic Search Ultimate